IMDX
Insight Molecular Diagnostics
IMDX
IMDX
45 hedge funds and large institutions have $21.7M invested in Insight Molecular Diagnostics in 2017 Q4 according to their latest regulatory filings, with 10 funds opening new positions, 15 increasing their positions, 3 reducing their positions, and 2 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
more ownership
Funds ownership: →
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
35% less capital invested
Capital invested by funds: $33.3M → $21.7M (-$11.6M)
Holders
45
Holding in Top 10
1
Calls
–
Puts
–
Top Buyers
| 1 | +$1.04M | |
| 2 | +$80.1K | |
| 3 | +$73K | |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$48K |
| 5 |
Morgan Stanley
New York
|
+$28.9K |
Top Sellers
| 1 | -$155K | |
| 2 | -$9.16K | |
| 3 | -$2K | |
| 4 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
-$1.4K |
| 5 |
Bank of New York Mellon
New York
|
-$1.3K |